Gut reservoir of E. coli ST131

大肠杆菌 ST131 的肠道储存库

基本信息

  • 批准号:
    9892970
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-01-01 至 2021-03-31
  • 项目状态:
    已结题

项目摘要

A new Escherichia coli strain called ST131-H30 – unknown prior to 2000 – is now the single most common cause of E. coli infections such as urinary tract infections, particularly those associated with resistance to first- line antibiotics. Veterans are especially vulnerable to ST131-H30, which causes 25-30% of all their E. coli infections, and 70-75% of those involving fluoroquinolone (e.g., ciprofloxacin) resistance. Gut colonization is an important upstream step in ST131-H30 infections, and therefore is a key part of the ST131-H30 epidemic. We have found that, in veterans and their household members, gut colonization with fluoroquinolone-resistant E. coli (12-13% overall) is quite prolonged (possibly years), is significantly longer for ST131-H30 than other resistant E. coli, and is attributable more to strain persistence than frequent transmission. This suggests the possibility of reducing gut colonization with ST131-H30 by identifying modifiable risk factors, host immune factors, bacterial traits, and characteristics of the gut microbiota that correlate with prolonged H30 colonization and loss of colonization, to inform the development of appropriate interventions. Accordingly, we propose to augment our current longitudinal fecal surveillance of H30-colonized veterans and household members by: · identifying epidemiological risk factors for presence and loss of H30 colonization · identifying humoral and cell-mediated immune correlates of presence and loss of H30 colonization · identifying genomic differences between initial vs. final, and shorter vs. longer-persisting, fecal ST131- H30 isolates · identifying shifts in the gut microbiota (i.e., bacterial community and E. coli population) that correspond with presence and loss of H30 colonization. The results of these studies can be expected to provide essential information needed for the design of interventions (e.g., risk factor modification, vaccines, anti-colonization drugs, and pre- or probiotics) to reduce gut colonization with the ST131-H30 strains that cause infections in veterans. Such interventions should help to reduce the enormous disease burden from infections caused by multi-resistant E. coli, mainly ST131-H30.
一种名为ST 131-H30的新大肠杆菌菌株-在2000年之前未知-现在是最常见的 由于E.大肠杆菌感染,如尿路感染,特别是与耐第一- 线抗生素。退伍军人特别容易感染ST 131-H30,这导致他们所有E。杆菌 感染,和70-75%的涉及氟喹诺酮的那些(例如,环丙沙星)抗性。肠道殖民是一种 在ST 131-H30感染的重要上游步骤,因此是ST 131-H30流行病的关键部分。我们 已经发现,在退伍军人和他们的家庭成员,肠道定植与氟喹诺酮耐药E。 大肠杆菌(总体为12-13%)是相当长的(可能是几年),ST 131-H30比其他 抗性大肠大肠杆菌,并归因于菌株的持久性比频繁的传播。这表明 通过鉴定可改变的风险因素、宿主免疫和/或免疫调节因子, 与H30长期定植相关的因素、细菌性状和肠道微生物群特征 和殖民化的丧失,为制定适当的干预措施提供信息。因此,我们建议 通过以下方式加强我们目前对H30定植退伍军人和家庭成员的纵向粪便监测: ·确定H30定殖存在和丧失的流行病学风险因素 ·鉴定H30定殖的存在和丧失的体液和细胞介导的免疫相关性 ·鉴定初始与最终,以及较短与较长持续时间的粪便ST 131之间的基因组差异- H30分离株 ·识别肠道微生物群的变化(即,细菌群落和E.大肠杆菌群体), H30定殖的存在和丧失。 这些研究的结果可以预期提供设计所需的基本信息 干预(例如,风险因素修饰、疫苗、抗定植药物和益生菌),以减少 肠道定植ST 131-H30菌株,导致退伍军人感染。这些干预措施应有助于 以减少多重耐药大肠杆菌感染所造成的巨大疾病负担。coli,主要为ST 131-H30。

项目成果

期刊论文数量(45)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Treatment of ED patients with bacteriuria/pyuria of clinically undetermined significance.
治疗临床意义未确定的菌尿/脓尿 ED 患者。
Colonisation with ESBL-producing and carbapenemase-producing Enterobacteriaceae, vancomycin-resistant enterococci, and meticillin-resistant Staphylococcus aureus in a long-term care facility over one year.
  • DOI:
    10.1186/s12879-015-0880-5
  • 发表时间:
    2015-04-01
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Ludden C;Cormican M;Vellinga A;Johnson JR;Austin B;Morris D
  • 通讯作者:
    Morris D
Horizontally acquired papGII-containing pathogenicity islands underlie the emergence of invasive uropathogenic Escherichia coli lineages.
  • DOI:
    10.1038/s41467-020-19714-9
  • 发表时间:
    2020-11-24
  • 期刊:
  • 影响因子:
    16.6
  • 作者:
    Biggel M;Xavier BB;Johnson JR;Nielsen KL;Frimodt-Møller N;Matheeussen V;Goossens H;Moons P;Van Puyvelde S
  • 通讯作者:
    Van Puyvelde S
Draft genome sequences of concurrent Escherichia coli blood and fecal isolates from a patient with bacteremia and diarrhea belie BioFire-based detection of fecal enteropathogenic E. coli.
从患有菌血症和腹泻的患者身上同时分离出的大肠杆菌血液和粪便的基因组序列草图与基于 BioFire 的粪便肠病性大肠杆菌检测不符。
  • DOI:
    10.1093/femspd/ftaa058
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    3.3
  • 作者:
    Singh,PradipKumar;Johnston,BrianD;Johnson,JamesR;Donnenberg,MichaelS
  • 通讯作者:
    Donnenberg,MichaelS
Bacterial "Virulence" Traits and Host Demographics Predict Escherichia coli Colonization Behaviors Within Households.
  • DOI:
    10.1093/ofid/ofaa495
  • 发表时间:
    2020-11
  • 期刊:
  • 影响因子:
    4.2
  • 作者:
    Fox TC;Clabots C;Porter SB;Bender T;Thuras P;Colpan A;Boettcher J;Johnson JR
  • 通讯作者:
    Johnson JR
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JAMES R JOHNSON其他文献

JAMES R JOHNSON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JAMES R JOHNSON', 18)}}的其他基金

E. coli ST131 and Intestinal Colonization
大肠杆菌 ST131 和肠道定植
  • 批准号:
    8904313
  • 财政年份:
    2014
  • 资助金额:
    --
  • 项目类别:
E. coli ST131 and Intestinal Colonization
大肠杆菌 ST131 和肠道定植
  • 批准号:
    8644347
  • 财政年份:
    2014
  • 资助金额:
    --
  • 项目类别:
Emergence of E. coli sequence type ST131
ST131 型大肠杆菌序列的出现
  • 批准号:
    8195979
  • 财政年份:
    2009
  • 资助金额:
    --
  • 项目类别:
Emergence of E. coli sequence type ST131
ST131 型大肠杆菌序列的出现
  • 批准号:
    7689060
  • 财政年份:
    2009
  • 资助金额:
    --
  • 项目类别:
Emergence of E. coli sequence type ST131
ST131 型大肠杆菌序列的出现
  • 批准号:
    8390429
  • 财政年份:
    2009
  • 资助金额:
    --
  • 项目类别:
Emergence of E. coli sequence type ST131
ST131 型大肠杆菌序列的出现
  • 批准号:
    7783809
  • 财政年份:
    2009
  • 资助金额:
    --
  • 项目类别:
Prolonged Analgesia in Rodents
啮齿类动物的长期镇痛
  • 批准号:
    7329096
  • 财政年份:
    2007
  • 资助金额:
    --
  • 项目类别:
Resistant E. coli in Humans and Poultry
人类和家禽中的耐药大肠杆菌
  • 批准号:
    6909507
  • 财政年份:
    2004
  • 资助金额:
    --
  • 项目类别:
Resistant E.coli in Humans and Poultry
人类和家禽中的耐药大肠杆菌
  • 批准号:
    6946917
  • 财政年份:
    2004
  • 资助金额:
    --
  • 项目类别:
Infectious Disease Training in Clinical Investigation
临床研究中的传染病培训
  • 批准号:
    7694026
  • 财政年份:
    2003
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了